From: HPV-based cervical cancer screening in Nicaragua: from testing to treatment
Ā | Total Triaged N (%) | Triaged with Pap N (%) | Triaged with VIA N (%) | P valueā” |
---|---|---|---|---|
Women triaged | 3656 (100) | 2784 (100) | 872 (100) | <ā0.001 |
Triage result | ||||
āNegative | 2293 (62.7) | 1851 (66.6) | 442 (50.7) | <ā0.001 |
āPositivea | 915 (25.0) | 513 (21.7) | 402 (46.1) | <ā0.001 |
āUnknown | 448 (12.3) | 420 (15.1) | 28 (3.2) | <ā0.001 |
Treated | 486 (13.3) | 132 (4.7)b | 361 (41.4) | <ā0.001 |
Percent treated among triage-positive women | 53.1 | 25.7 | 89.8 | Ā |
Number of days from screening to triage | ||||
N (women with available data) | 2566 (70.2) | 2089 | 477 | Ā |
Mean (SD) | 61.9 (SD: 43.8) | 58.1 (SD: 37.7) | 78.6 (SD: 61.5) | <ā0.001 |
Number of days from triage to treatment | ||||
N (women with available data) | 470 (51.3c) | 116 | 318 | Ā |
Treated on same day | 263 (56.0) | 2 (1.7) | 262 (82.4) | <ā0.01 |
Mean days if not treated on same day (SD) | 89.2 (SD 86.5) | 103.8 (SD 93.4) | 75.2 (SD 83.6) | 0.05 |